YS BIOPHARMA CO LTD (YS)
KYG9845F1090 - Common Stock
| TTM (2022-9-30) | 2023 (2023-3-31) | 2022 (2021-12-31) | 2021 (2020-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 25.33M | -145.48M | -545.73K | -3.64K | -3.64K | |||
| Depreciation Amortization | N/A | 36.69M | 31.15M | N/A | N/A | |||
| Income Taxes - Deferred | N/A | 1.13M | 4.94M | N/A | N/A | |||
| Change In Working Capital | 155.86K | -92.75M | 443.37K | 443.37K | N/A | |||
| Interest Paid | N/A | 27.29M | 2.40M | N/A | N/A | |||
| Taxes Paid | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Other non cash items | -26.04M | 17.93M | -510.87K | 3.64K | 3.64K | |||
| OPERATING CASH FLOW | -556.79K | -182.47M | -613.23K | 0.00 | 0.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -57.05M | -298.93M | N/A | N/A | |||
| Other Investing Activity | N/A | 68.00K | -200.00M | -200.00M | N/A | |||
| INVESTING CASH FLOW | N/A | -56.98M | -200.00M | -200.00M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 100.88M | -361.02K | -361.02K | N/A | |||
| Stock Issued/Repurchased | N/A | N/A | 202.00M | 202.00M | N/A | |||
| Other Financing Activity | N/A | 216.57M | -140.55K | -140.55K | N/A | |||
| FINANCING CASH FLOW | N/A | 317.45M | 201.50M | 201.50M | N/A | |||
| Exchange Rate Effect | N/A | 21.30M | -11.48M | N/A | N/A | |||
| CHANGE IN CASH | -2.06M | 99.30M | 885.19K | 0.00 | 0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -556.79K | -182.47M | -613.23K | 0.00 | 0.00 | |||
| Capital Expenditure | N/A | -57.05M | -298.93M | N/A | N/A | |||
| FREE CASH FLOW | -556.79K | -239.52M | -613.23K | 0.00 | 0.00 | |||
All data in CNY